Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Completed 16Terminated 12Recruiting 7Unknown 4Withdrawn 3Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 69Lymphoid 58Other hematologic neoplasm 27Gastrointestinal 8Thoracic 4Myeloid 3Genitourinary 3CNS 3Breast 3Other 2Tumor-Agnostic 1Sarcoma 1Other solid neoplasm 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Lung Neoplasms 3Vomiting 2Nausea 2Neoplasms 1Mesothelioma 1Melanoma 1Diabetes Mellitus 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Carboplatin 133Cisplatin 130Pemetrexed 114Docetaxel 79Drug Therapy 61Gefitinib 57anlotinib 55Gemcitabine 55Erlotinib Hydrochloride 55Radiotherapy 48Bevacizumab 48pembrolizumab 47Paclitaxel 47Etoposide 44apatinib 42icotinib 41camrelizumab 39osimertinib 35Vinorelbine 31Nivolumab 31Radiosurgery 30sintilimab 29aumolertinib 25endostar protein 24durvalumab 24atezolizumab 23Endostatins 22Blood Specimen Collection 19toripalimab 18Immune Checkpoint Inhibitors 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Dexamethasone × Thoracic × Clear all
NCT04201769 2020-04-03

LUNG-NEPA

Consorzio Oncotech

Phase 3 Unknown
261 enrolled
Thoracic

Lung Neoplasms, Nausea, Vomiting

NCT04001725 2019-11-13

OPTIMAL

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
110 enrolled
BreastCNSDermatologicThoracic

Brain Neoplasms, Breast Neoplasms, Diabetes Mellitus, Lung Neoplasms, Melanoma, Neoplasms

NCT02445872 2015-12-09

Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy

Zhejiang University

Phase 2 Unknown
80 enrolled
Thoracic

Lung Neoplasms, Nausea, Vomiting

NCT01569919 2013-03-12

SKOPOS

Wales Cancer Trials Unit

Phase 2 Unknown
26 enrolled
Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡